- Raw materials
- Antioxidants
- Chromanol
Chromanol API Manufacturers & Suppliers
0 verified results
All Chromanol data. Full access. Full negotiation power
Commercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Chromanol | CAS No: 950-99-2 | GMP-certified suppliers
A medication that serves as an antioxidant and protective agent primarily investigated for prostate cancer research and related therapeutic applications.
Therapeutic categories
Product Snapshot
- Chromanol is formulated as an oral small molecule
- It is primarily investigated for cardiovascular and metabolic indications
- The compound is currently in the investigational stage and not yet approved by major regulatory authorities
Clinical Overview
Pharmacodynamic and mechanistic details of Chromanol remain unspecified in the available literature. It is broadly recognized as an antioxidant and protective agent, consistent with properties attributed to benzopyran derivatives. Its mechanism of action and direct biological targets have not been clearly defined and warrant further investigation to elucidate its role in cellular or molecular pathways relevant to disease modulation.
Absorption, distribution, metabolism, and excretion (ADME) parameters for Chromanol have not been publicly documented, limiting comprehensive understanding of its pharmacokinetic profile. Safety and toxicity data are similarly limited, reflecting its investigational status and use primarily in preclinical or early clinical research settings. No marketed pharmaceutical products or widely recognized brand names are associated with Chromanol.
Given its investigational classification, sourcing of Chromanol APIs requires strict adherence to quality and regulatory standards to ensure chemical purity and consistency. Suppliers should provide detailed certificates of analysis and comply with good manufacturing practice (GMP) guidelines. Analytical characterization including identity confirmation, impurity profiling, and stability assessment is essential to meet research or development requirements. Procurement decisions should consider traceability, vendor reliability, and compliance with applicable international regulations.
Identification & chemistry
| Generic name | Chromanol |
|---|---|
| Molecule type | Small molecule |
| CAS | 950-99-2 |
| UNII | 7G73627R36 |
| DrugBank ID | DB13111 |
Formulation & handling
- Chromanol is a small molecule with moderate lipophilicity, suitable for oral formulation development. Low aqueous solubility suggests potential need for solubilization strategies or formulation approaches to enhance bioavailability. Stability and handling conditions should consider its investigational status and chemical class but no specific peptide or biologic sensitivities apply.
Regulatory status
Chromanol is a type of Antioxidants
Antioxidants are a vital category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a crucial role in preventing oxidative damage and promoting overall health. Oxidative stress occurs when there is an imbalance between the production of reactive oxygen species (ROS) and the body's antioxidant defense mechanisms.
Antioxidants function by neutralizing ROS and minimizing the potential harm they can cause to cells and tissues. This category includes a diverse range of compounds, such as vitamins (e.
g.
, vitamin C, vitamin E), minerals (e.
g.
, selenium, zinc), and phytochemicals (e.
g.
, polyphenols, flavonoids). These antioxidants can be obtained from natural sources like fruits, vegetables, and herbs, or they can be synthesized in laboratories for pharmaceutical use.
The role of antioxidants in the prevention and treatment of various diseases has been extensively studied. They have demonstrated the ability to reduce the risk of chronic diseases like cardiovascular disorders, cancer, and neurodegenerative conditions. Moreover, antioxidants exhibit anti-inflammatory properties, enhance immune function, and protect against age-related damage.
In the pharmaceutical industry, antioxidants are widely utilized as key ingredients in the formulation of drugs, dietary supplements, and cosmetic products. They contribute to the stability and shelf life of pharmaceutical preparations by preventing oxidative degradation. Antioxidant APIs are manufactured with strict quality control measures to ensure purity, efficacy, and safety.
In conclusion, antioxidants are essential pharmaceutical APIs that provide numerous health benefits. Their ability to counteract oxidative stress and protect cells from damage makes them a valuable component in the prevention and treatment of various diseases. The pharmaceutical industry relies on these antioxidants to enhance the quality and efficacy of their products, making them indispensable in the field of healthcare.
